AstraZeneca PLC
USD190.95
+2.54 (+1.35%)
CEO
Pascal Claude Roland Soriot
IPO Date
1993-05-12
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Country
GB
Open
$189.25
Prev. Close
$188.41
Day Low
$188.46
Day High
$191.12
52W Low
$137.22
52W High
$212.71
Market Cap
$296.14B
Volume
1.52M
| 29.5 |
| 31 Dec 2023 | FY | 73.9% | 13.0% | 15.5% | 6.0% | 0.73 | 0.81 | 34.8 |
| 31 Dec 2022 | FY | 63.4% | 7.4% | 8.9% | 3.4% | 0.79 | 0.86 | 64.0 |
| 31 Dec 2021 | FY | 60.9% | 0.3% | 0.3% | 0.1% | 0.78 | 1.16 | 1515.9 |
| 31 Dec 2020 | FY | 74.0% | 11.6% | 21.7% | 5.1% | 1.30 | 0.96 | 38.7 |
| 31 Dec 2019 | FY | 72.4% | 5.5% | 10.2% | 2.2% | 1.39 | 0.86 | 97.8 |
| 31 Dec 2018 | FY | 71.8% | 9.8% | 16.4% | 3.4% | 1.53 | 0.95 | 46.3 |
| 31 Dec 2017 | FY | 74.1% | 13.4% | 20.9% | 4.9% | 1.19 | 0.80 | 28.0 |
| 31 Dec 2016 | FY | 75.8% | 15.2% | 21.4% | 5.1% | 1.13 | 0.87 | 21.7 |
| 30.9 |
| 30 Sept 2025 | Q3 | 81.2% | 16.7% | 5.5% | 2.2% | 0.71 | 0.88 | 23.2 |
| 30 Jun 2025 | Q2 | 75.2% | 16.9% | 5.6% | 2.2% | 0.73 | 0.86 | 21.4 |
| 30 Mar 2025 | Q1 | 76.4% | 21.5% | 7.3% | 2.8% | 0.76 | 0.90 | 18.8 |
| 31 Dec 2024 | Q4 | 67.7% | 10.1% | 3.6% | 1.4% | 0.74 | 0.93 | 34.7 |
| 30 Sept 2024 | Q3 | 71.1% | 10.5% | 3.6% | 1.4% | 0.78 | 0.93 | 40.9 |
| 30 Jun 2024 | Q2 | 75.7% | 14.9% | 4.9% | 1.9% | 0.85 | 0.89 | 31.3 |
| 31 Mar 2024 | Q1 | 75.2% | 17.2% | 5.8% | 2.1% | 0.92 | 0.88 | 23.9 |
| 31 Dec 2023 | Q4 | 72.6% | 8.0% | 2.5% | 1.0% | 0.73 | 0.81 | 53.4 |